BASF India Limited — Investor Meet, 21-11-2025: Analysts/Institutional Investor Meet/Con. Call Updates
BASF India reported H1 FY26 sales down 4% to Rs. 7900 Cr and PBT down 27% due to higher input costs and an unfavorable product mix. Q2 sales fell 5%, PBT 16%. Nutrition & Care was a strong performer, seeing a 50% PBT increase.
Management noted a tough monsoon impacted Ag Solutions, though new products like Valexio are performing well. Chemical pricing remains challenged by China's overcapacity. The strategic demerger of Ag Solutions and a coatings joint venture are on track to unlock value.
The company is investing in its Celesto and engineering plastics businesses, enhancing green energy usage, and focusing on cost efficiency and asset utilization. Management maintains a focused stance, aiming to leverage India's growth while navigating sector-specific challenges.
